Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Jul;52(1):65–72. doi: 10.1038/bjc.1985.150

Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.

H Ben-Aissa, S Paulie, H Koho, P Biberfeld, Y Hansson, M L Lundblad, H Gustafson, I Jonsdottir, P Perlmann
PMCID: PMC1977157  PMID: 4015953

Abstract

Mice were immunized with cultured cells derived from transitional cell carcinoma of the human urinary bladder (TCC). Spleen cells were fused with mouse myeloma cell line Sp2/0-Ag14 and the hybridomas obtained screened for antibody production against a panel of human cells. Two hybridomas were selected for further studies. The antibodies from one of these hybridomas (P7A5-4) could clearly discriminate between malignant and normal cells from the bladder, both when tested with cultured cells and fresh tissue. The P7A5-4 antibodies, however, also reacted with some non-TCC cultured carcinoma and melanoma cells but to a lesser extent. This difference in reactivity was even more pronounced in the fresh tumours tested, thus indicating a quantitative difference in antigen expression between TCC and other cells. From extracts of TCC cells, P7A5-4 bound three polypeptides of mol. wts 92Kd (ConA+), 23 and 17Kd (ConA-). The antibody derived from hybridoma SK4H-12 bound a ConA reactive glycopeptide of 100Kd mol. wt, the expression of which was almost entirely restricted to urothelial cell lines and tissue of TCC origin, as shown by immunocytochemical studies. The finding in this study of new antigens associated with urinary bladder carcinoma, extend the results obtained previously in our laboratory (Koho et al., 1984; Paulie et al., 1984) and further delineate the heterogeneity of tumour-associated antigens in this human tumour system.

Full text

PDF
65

Images in this article

67Figure 1
on p.67
69Figure 2
on p.69
70Figure 3
on p.70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CLARK H. F., SHEPARD C. C. A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. Virology. 1963 Aug;20:642–644. doi: 10.1016/0042-6822(63)90292-7. [DOI] [PubMed] [Google Scholar]
  2. Chang E. H., Furth M. E., Scolnick E. M., Lowy D. R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature. 1982 Jun 10;297(5866):479–483. doi: 10.1038/297479a0. [DOI] [PubMed] [Google Scholar]
  3. Dippold W. G., Lloyd K. O., Li L. T., Ikeda H., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114–6118. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971 Sep;8(9):871–874. doi: 10.1016/0019-2791(71)90454-x. [DOI] [PubMed] [Google Scholar]
  5. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grossman H. B. Hybridoma antibodies reactive with human bladder carcinoma cell surface antigens. J Urol. 1983 Sep;130(3):610–614. doi: 10.1016/s0022-5347(17)51324-5. [DOI] [PubMed] [Google Scholar]
  7. Imai K., Wilson B. S., Bigotti A., Natali P. G., Ferrone S. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells. J Natl Cancer Inst. 1982 May;68(5):761–769. [PubMed] [Google Scholar]
  8. Koho H., Paulie S., Ben-Aissa H., Jónsdóttir I., Hansson Y., Lundblad M. L., Perlmann P. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol Immunother. 1984;17(3):165–172. doi: 10.1007/BF00205481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Larson S. M., Brown J. P., Wright P. W., Carrasquillo J. A., Hellström I., Hellström K. E. Imaging of melanoma with L-131-labeled monoclonal antibodies. J Nucl Med. 1983 Feb;24(2):123–129. [PubMed] [Google Scholar]
  10. Mach J. P., Chatal J. F., Lumbroso J. D., Buchegger F., Forni M., Ritschard J., Berche C., Douillard J. Y., Carrel S., Herlyn M. Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res. 1983 Nov;43(11):5593–5600. [PubMed] [Google Scholar]
  11. Maki R., Traunecker A., Sakano H., Roeder W., Tonegawa S. Exon shuffling generates an immunoglobulin heavy chain gene. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2138–2142. doi: 10.1073/pnas.77.4.2138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Masuko T., Yagita H., Hashimoto Y. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells. J Natl Cancer Inst. 1984 Mar;72(3):523–530. [PubMed] [Google Scholar]
  13. Messing E. M., Bubbers J. E., Whitmore K. E., deKernion J. B., Nestor M. S., Fahey J. L. Murine hybridoma antibodies against human transitional carcinoma-associated antigens. J Urol. 1984 Jul;132(1):167–172. doi: 10.1016/s0022-5347(17)49512-7. [DOI] [PubMed] [Google Scholar]
  14. Nakane P K, Pierce G B., Jr Enzyme-labeled antibodies: preparation and application for the localization of antigens. J Histochem Cytochem. 1966 Dec;14(12):929–931. doi: 10.1177/14.12.929. [DOI] [PubMed] [Google Scholar]
  15. Nayak S. K., O'Toole C., Price Z. H. A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br J Cancer. 1977 Feb;35(2):142–151. doi: 10.1038/bjc.1977.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O'Toole C. M., Povey S., Hepburn P., Franks L. M. Identity of some human bladder cancer cell lines. Nature. 1983 Feb 3;301(5899):429–430. doi: 10.1038/301429a0. [DOI] [PubMed] [Google Scholar]
  17. O'Toole C. M., Tiptaft R. C., Stevens A. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity. Int J Cancer. 1982 Apr 15;29(4):391–395. doi: 10.1002/ijc.2910290405. [DOI] [PubMed] [Google Scholar]
  18. Paulie S., Hansson Y., Lundblad M. L., Perlmann P. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines. Int J Cancer. 1983 Mar 15;31(3):297–303. doi: 10.1002/ijc.2910310308. [DOI] [PubMed] [Google Scholar]
  19. Paulie S., Koho H., Ben-Aissa H., Hansson Y., Lundblad M. L., Perlmann P. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis. Cancer Immunol Immunother. 1984;17(3):173–179. doi: 10.1007/BF00205482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sears H. F., Herlyn D., Steplewski Z., Koprowski H. Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J Biol Response Mod. 1984;3(2):138–150. [PubMed] [Google Scholar]
  21. Suter L., Brüggen J., Sorg C. Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens. J Immunol Methods. 1980;39(4):407–411. doi: 10.1016/0022-1759(80)90241-0. [DOI] [PubMed] [Google Scholar]
  22. Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4515–4519. doi: 10.1073/pnas.78.7.4515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vilien M., Christensen B., Wolf H., Rasmussen F., Hou-Jensen C., Povlsen C. O. Comparative studies of normal, 'spontaneously' transformed and malignant human urothelium cells in vitro. Eur J Cancer Clin Oncol. 1983 Jun;19(6):775–789. doi: 10.1016/0277-5379(83)90010-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES